Crohn’s disease and ulcerative colitis are chronic, relapsing inflammatory bowel diseases (IBDs). Treatment of IBD is directed at induction and maintenance of disease remission, to improve clinical symptoms, prevent disease-related complications and minimize treatment-related risk.
Based on AGA’s Inflammatory Bowel Disease clinical guidance, our quality team has developed three quality measures to guide you in providing high-quality IBD care.